Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	35.11B +24.8%
Revenue (ttm)	6.29B +12.8%
Net Income	1.04B +35.1%
EPS	2.86 +32.4%
Shares Out	359.69M
PE Ratio	34.91
Forward PE	27.48
Dividend	1.10 (1.10%)
Ex-Dividend Date	Jun 26, 2025

Volume	4,103,716
Average Volume	3,523,102
Open	96.18
Previous Close	96.80
Day's Range	96.01 - 100.65
52-Week Range	59.90 - 125.50
Beta	0.23
RSI	54.25
Earnings Date	Mar 30, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.